AI-generated summary
The authors randomized 30 inpatients with a major depressive episode, most with major depressive disorder and some with bipolar disorder, to citalopram plus either morning green light therapy or a placebo device. They report that light-treated patients showed significantly better mood improvement and faster antidepressant response on all outcome measures. The abstract describes the study as small and does not report a total sample of more than 30.
- Participants
- 30
- Who or what was studied
- Inpatients with a major depressive episode without psychotic features, including DSM-IV major depressive disorder (N = 21) and bipolar disorder (N = 9)
- Limits stated in the abstract
- The abstract reports a small sample of 30 inpatients, and the bipolar and unipolar patients were combined in one analysis.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatrist.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Placebo-controlled, Depression, Visual analogue scale, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.